Analyst Rating: Will Hologic, Inc. (HOLX) Stock Outperform the Market?

Wall Street is positive on Hologic, Inc. (HOLX). On average, analysts give the stock a Buy rating. The average price target is $81.363, which means analysts expect the stock to gain by 16.10% over the next twelve months. That average ranking earns the stock an Analyst Rating of 30, which is better than 30% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating HOLX a Buy today. Find out what this means to you and get the rest of the rankings on HOLX!

See Full HOLX Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Hologic, Inc. Stock Today?

Hologic, Inc. (HOLX) stock is down -2.03% while the S&P 500 is higher by 0.05% as of 2:53 PM on Tuesday, Nov 28. HOLX has fallen -$1.46 from the previous closing price of $71.53 on volume of 1,001,800 shares. Over the past year the S&P 500 is up 14.85% while HOLX has fallen -5.10%. HOLX earned $1.83 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 38.15. Click Here to get the full Stock Report for Hologic, Inc. stock.